• Working in the present,
    thinking the future

  • Health, our greatest asset value

  • Pharmacovigilance

  • Patient Centricity

We provide drugs with a high added value for health care and treatments for high complexity diseases, for both overall patients and the medical and scientific community

Our products

are mainly addressed to be used in hematologic, oncologic, urologic, neurologic and nephrologic pathologies as well as rare diseases

News

NEW PRODUCT LAUNCH ANTIXAN® edaravone

28/07/2021

Committed to our mission of providing high value-added drugs for the medical community and patients, we make available the new product ANTIXAN® edaravone for the treatment of Amyotrophic Lateral Sclerosis.

(Español) NUEVO LANZAMIENTO IBRULEU® ibrutinib

04/06/2021

(Español) Desde Bioprofarma Bagó nos complace presentar nuestro nuevo producto IBRULEU® ibrutinib

(Español) Ateneo Hospital Pirovano

28/05/2021

(Español) Nos complace compartirles la disertación de la Dra. Ana Acosta en el ateneo del Hospital Pirovano

Bioprofarma Bagó worldwide